Kava extract in Huntington's disease: A double-blind, placebo-controlled, dose-escalation crossover study

被引：0
|
作者：
Hogarth, P.
Crossen, E.
机构：
来源：
MOVEMENT DISORDERS | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P421
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled, dose-escalation trial of pimavanserin in Parkinson's disease and psychosis
    Revell, Stephen
    Friedman, Joseph
    Mills, Roger G.
    Williams, Hilde
    Johnson, Ann D.
    Bahr, Daun
    NEUROLOGY, 2008, 70 (11) : A284 - A285
  • [2] A double-blind, placebo-controlled, dose-escalation trial of pimavanserin in Parkinson's disease and psychosis
    Mills, R.
    Revell, S.
    Bahr, D.
    Williams, H.
    Johnson, A.
    Friedman, J. H.
    MOVEMENT DISORDERS, 2008, 23 (01) : S221 - S222
  • [3] Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose
    Pahwa, Rajesh
    Koller, William C.
    Trosch, Richard M.
    Sherry, James H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 258 (1-2) : 137 - 143
  • [4] Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study
    Adams, HP
    Bogousslavsky, J
    Barnathan, E
    Brott, T
    Fisher, M
    Furlan, AJ
    Graffagnino, C
    Kappelle, J
    Kothari, R
    Leclerc, JR
    Moulin, T
    Polzer, J
    Torner, J
    Worley, S
    Haley, CE
    Day, JH
    Levine, SR
    Thompson, JLP
    Sherman, DG
    Sane, DC
    Maley, JE
    Grimsman, KJ
    Maeder, M
    Clarke, WR
    Anderson, K
    Cook, R
    FitzPatrick, S
    Peeters, A
    Cras, P
    Blecic, S
    Laloux, P
    Chatel, M
    Mahagne, H
    Moulin, T
    Hacke, W
    Diener, HC
    Bogousslavsky, J
    Maeder, M
    Kappelle, LJ
    Vermulen, M
    Kwa, VIH
    Franke, CL
    Jacoby, M
    Libman, R
    Hsu, C
    Kothari, R
    Raps, EC
    Kasner, SE
    Scott, P
    Karanjia, P
    STROKE, 2000, 31 (03) : 601 - 609
  • [5] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED DOSE-ESCALATION PHASE 1 STUDY OF AEROSOLIZED PIRFENIDONE
    Khoo, J.
    Montgomery, B.
    Otto, K.
    Surber, M.
    Glaspole, I
    RESPIROLOGY, 2019, 24 : 177 - 177
  • [6] Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study
    Tehranchi, Ramin
    Pettersson, Jonas
    Melgaard, Anita E.
    Seitz, Friedeborg
    Valeur, Anders
    Maarbjerg, Stine Just
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2022, 96
  • [7] An evaluation of NBI-827104 for essential tremor: results from a randomized, double-blind, placebo-controlled, dose-escalation, crossover study
    de Cuba, C.
    Smits, L.
    Kremer, P.
    Doll, R. J.
    Heuberger, J.
    Helmich, R.
    van Rootselaar, A. F.
    Elble, R.
    Ondo, W.
    Rees, L.
    Wedick, N.
    Liang, G.
    Haubenberger, D.
    MOVEMENT DISORDERS, 2023, 38 : S426 - S426
  • [8] A double blind, placebo-controlled crossover study of the effect of amantadine on chorea in Huntington's disease
    Verhagen, L
    Morris, M
    Farmer, C
    Gillespie, M
    Wuu, J
    Chase, TN
    NEUROLOGY, 2001, 56 (08) : A386 - A386
  • [9] Does a Medicinal Dose of Kava Impair Driving? A Randomized, Placebo-Controlled, Double-Blind Study
    Sarris, J.
    Laporte, E.
    Scholey, A.
    King, R.
    Pipingas, A.
    Schweitzer, I.
    Stough, C.
    TRAFFIC INJURY PREVENTION, 2013, 14 (01) : 13 - 17
  • [10] A Prospective, Randomized, Placebo-Controlled Double-Blind, Dose-Escalation Trial of Pyridostigmine for Diabetes Mellitus and Constipation
    Bharucha, Adil F.
    Low, Phillip A.
    Camilleri, Michael
    Burton, Duane D.
    Kudva, Yogish C.
    Shah, Pankaj
    Zinsmeister, Alan R.
    GASTROENTEROLOGY, 2011, 140 (05) : S2 - S3
12345